Dyslipidemia of Obesity Intervention in Teens

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

April 21, 2023

Study Completion Date

June 30, 2023

Conditions
DyslipidemiaObesity
Interventions
DRUG

Pitavastatin

Statin

DRUG

Placebo

Placebo

Trial Locations (16)

15224

Children's Hospital of Pittsburgh, Pittsburgh

19104

The Children's Hospital of Philadelphia, Philadelphia

19803

Nemours/Alfred I duPont Hospital for Children, Wilmington

20010

Children's National Health System, Washington D.C.

21287

Johns Hopkins University School of Medicine, Baltimore

29425

Medical University of South Carolina, Charleston

30322

Emory University School of Medicine, Atlanta

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

46202

Riley Hospital for Children at IU Health, Indianapolis

53792

University of Wisconsin, Madison

63110

Washington University School of Medicine, St Louis

64108

Children's Mercy Hospital, Kansas City

77030

Texas Children's Hospital, Houston

84108

Primary Children's Hospital, University of Utah, Salt Lake City

02114

Boston Children's Hospital, Boston

M5g 1X8

The Hospital for Sick Children, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Carelon Research

OTHER

NCT02956590 - Dyslipidemia of Obesity Intervention in Teens | Biotech Hunter | Biotech Hunter